Weekly Recap: Oil, Iran, and the Art of Holding Through Noise

Happy Saturday. Pour yourself something warm, close the trading apps, and let's look back at the week that was.

If I had to summarize this week in one sentence: geopolitics drove the bus, and everyone else was just a passenger. Oil climbed above $110 on escalating Iran tensions. Recession odds ticked higher on Wall Street. Pharmaceutical tariffs made a surprise appearance. And through all of it, U.S. equities finished Friday remarkably flat. the S&P 500 up just 0.11%, the Nasdaq up 0.18%, and the Dow down 0.13%. as if the market hadn't quite decided whether to worry or shrug.

Let's unpack what actually mattered.

The Iran Situation Is Real, and It's Priced Into Oil

The dominant story this week was Trump threatening additional strikes on Iran, which pushed crude above $110. If you read Thursday's piece, Energy Shock, Recession Fears, and the Search for Alternatives: What Today's Data Tells Investors, you know I flagged this exact dynamic: an oil shock colliding with softening economic data creates a genuinely tricky environment for investors.

Here's what I'm watching. By Friday, the first LNG tanker had exited the Strait of Hormuz along the Omani coast. That tells me shipping lanes are still open, which is the single most important practical indicator. If the Strait closes or becomes uninsurable, $110 oil becomes $140 oil in a hurry. We're not there yet. But the risk premium is real, and it's not going away over the weekend.

For context, petrol and diesel prices saw their biggest rise on record in March, and $4-a-gallon gas is already hitting U.S. consumer wallets. Interestingly, analysts noted this week that high gas prices alone won't trigger Fed rate hikes. and could actually lead to cuts if they slow economic activity enough. That's a nuanced point worth remembering: sometimes the thing that feels most inflationary (expensive gas) can actually be deflationary if it crushes demand elsewhere. The record fuel price increases we're seeing are a direct mechanism for that demand destruction. If consumers are spending more at the pump, they're spending less everywhere else.

How Our Positions Handled the Week

Let's talk about what matters most: our actual money.

ConocoPhillips (COP) is the obvious beneficiary here. We entered this position at $131.70 back on March 26th, and the thesis was straightforward: a quality energy company positioned to benefit from sustained higher oil prices driven by geopolitical risk. This week validated that thesis about as clearly as you could ask. With oil above $110 and the energy sector ETF (XLE) finishing Friday up 0.47%, energy remains one of the few sectors with a clear tailwind. I'm comfortable holding. The risk, of course, is a sudden diplomatic breakthrough that sends oil back to $90. I'd welcome that outcome for the world, even if it dents the trade.

Ethereum (ETH) is a different story. We entered at roughly $2,057, and as of Friday it's sitting at about $2,053. basically flat, down about 0.16% from entry. I'll be honest: in a week dominated by geopolitical risk and recession fears, crypto holding its ground isn't the worst outcome. But it's not the momentum trade I initially flagged. The risk-on sentiment I was hoping for hasn't materialized yet, partly because investors are rotating toward hard assets like oil and away from speculative positions. So let me be clear about the catalyst I'm watching: ETH needs a sustained break above $2,200 to confirm the bullish thesis. If it breaks below $1,950, I'll reassess. Right now it's in no-man's land, and I'm treating it as a diversification bet rather than a conviction trade until the macro picture clears.

The Recession Question Everyone Is Asking

Recession odds climbed again this week. A global forecasting group put U.S. inflation at 4.2% for the year. well above the Fed's estimate. Private sector hiring came in at 62,000 for March, which was better than expected, but "better than expected" when expectations are already low isn't exactly a victory lap.

Meanwhile, the March jobs report was due Friday, and pre-release positioning likely contributed to the muted action in equities. Markets often go quiet ahead of major data releases, and the nearly flat Friday session across U.S. indexes (S&P 500 +0.11%, Dow -0.13%, Nasdaq +0.18%) is consistent with institutions waiting for fresh labor market data before making their next move.

Here's how I'm thinking about this. We're in a weird middle zone. Not enough weakness to trigger aggressive Fed cuts, not enough strength to ignore the warning signs. The 10-year yield finished Friday at 4.31%, and the 30-year at 4.89%. both ticking down fractionally on the day (10-year down 0.14%, 30-year down 0.20%). That modest decline in long-term yields, even as oil prices surged, tells you the bond market is weighing growth fears against inflation fears and leaning slightly toward the growth-concern side. Bond markets are pricing in persistent inflation with genuine growth worry underneath. That's a complicated signal.

What does it mean practically? It means staying diversified matters more than usual. It means high-quality positions with real cash flows (like COP) are more attractive than speculative bets. And it means keeping some dry powder isn't cowardice. it's patience.

The Tariff Wildcard

Almost lost in the Iran headlines: pharmaceuticals now face 100% tariffs in the U.S. unless companies strike a deal. Healthcare stocks felt the pressure, with XLV dropping 0.62% on Friday.

This isn't just a headline risk. it could be structural. One year into the broader tariff regime, we're already seeing four major ways Trump's tariffs have changed the global economy: supply chains have rewired, costs have shifted, and the cumulative drag on global trade is measurable. Pharmaceutical tariffs at 100% represent a significant escalation because healthcare is a defensive sector that many investors treat as a safe haven during uncertainty. If drug companies can't pass costs through or negotiate exemptions, margins compress. If they can pass costs through, drug prices rise, feeding directly into the inflation numbers that are already running at 4.2% by some estimates.

For broad market investors, the pharma tariff story matters beyond individual stock picks. It signals that tariff escalation isn't slowing down. it's accelerating into new sectors. That has implications for how you think about portfolio resilience across the board. I didn't have a healthcare position going into this, and I'm glad. But I'm watching closely, because defensive sectors becoming volatile changes the playbook for everyone.

What Surprised Me This Week

Two things caught me off guard.

First, the VIX dropping to 23.87 (down 2.73% on Friday) despite all these headlines. You'd expect volatility to be higher with oil above $110, recession odds climbing, and tariff escalation. The fact that it's relatively contained tells me institutional investors are hedged and waiting, not panicking. That's actually a constructive signal. it suggests the market is digesting bad news rather than being blindsided by it.

Second, the global market divergence on Friday was striking. South Korea's KOSPI surged 2.74% and Japan's Nikkei rallied 1.26%. both standing out against a sea of red across the rest of Asia and Europe. China's Shanghai Composite fell 1.0%, Hong Kong's Hang Seng dropped 0.70%, Taiwan sank 1.82%, and Australia lost 1.06%. In Europe, the Euro Stoxx 50 fell 0.70%, Germany's DAX dropped 0.56%, and France's CAC 40 slipped 0.24%. The UK's FTSE was a rare European bright spot, up 0.69%.

Why the split? South Korea and Japan are both major semiconductor and tech-export economies. Their outperformance on a day when most global markets pulled back suggests capital is flowing into export-oriented Asian tech. possibly a bet that these economies are better positioned to benefit from supply chain rewiring under the tariff regime, or that semiconductor demand remains resilient regardless of the macro cycle. It's worth watching whether this divergence continues, because persistent outperformance in Korea and Japan while China and Europe lag would tell us something important about where global growth expectations are shifting.

What to Watch Next Week

Here's the framework I'm using heading into Monday:

The Lesson From This Week

As I wrote in 7 Passive Income Ideas That Actually Work: Real Yields in April 2026, the investment landscape has shifted in 2026. Higher rates, geopolitical premiums in energy, and genuine economic uncertainty mean the playbook from 2024 doesn't work anymore.

But here's the thing I keep coming back to: weeks like this are exactly when long-term investment analysis matters most. The headlines are loud. The temptation is to react. And yet, when I look at our actual positions, COP is doing its job and ETH is holding water. Nothing required an emergency decision.

The best investors I know spend weekends like this one doing exactly what you're doing right now: reading, reflecting, and resisting the urge to make moves based on Friday's closing prices. Markets reopen Monday. The Iran situation will evolve. The jobs data will get digested. None of it requires action today.

So enjoy the weekend. I'll be back Monday with fresh data and, hopefully, a clearer picture of where we go from here.

This content is for educational and informational purposes only. It does not constitute financial advice. Always consult a qualified financial advisor before making investment decisions. Past performance does not guarantee future results.